Published in EBioMedicine on October 01, 2016
Hallmarks of cancer: the next generation. Cell (2011) 140.01
Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science (2009) 20.49
Acetylation is indispensable for p53 activation. Cell (2008) 5.70
Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS One (2009) 4.62
Modelling breast cancer: one size does not fit all. Nat Rev Cancer (2007) 3.64
New and emerging HDAC inhibitors for cancer treatment. J Clin Invest (2014) 3.35
G protein-coupled receptors: novel targets for drug discovery in cancer. Nat Rev Drug Discov (2011) 3.31
Physiological roles of G protein-coupled receptor kinases and arrestins. Annu Rev Physiol (2007) 3.27
Selective estrogen receptor modulators: discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells. Cancer Res (2004) 3.22
Mitogenic signaling pathways induced by G protein-coupled receptors. J Cell Physiol (2007) 2.97
The cytoplasmic deacetylase HDAC6 is required for efficient oncogenic tumorigenesis. Cancer Res (2008) 2.17
The ErbB/HER family of protein-tyrosine kinases and cancer. Pharmacol Res (2013) 2.17
PIN1 is an E2F target gene essential for Neu/Ras-induced transformation of mammary epithelial cells. Mol Cell Biol (2002) 2.12
Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins. Trends Biochem Sci (2011) 1.98
Molecular biology in breast cancer: intrinsic subtypes and signaling pathways. Cancer Treat Rev (2011) 1.98
A Pin1/mutant p53 axis promotes aggressiveness in breast cancer. Cancer Cell (2011) 1.95
SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis. Cell Death Differ (2011) 1.76
Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer. Cancer Treat Rev (2013) 1.73
Breast cancer - one term, many entities? J Clin Invest (2011) 1.72
Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis. EMBO J (2004) 1.62
Regulation of epidermal growth factor receptor trafficking by lysine deacetylase HDAC6. Sci Signal (2009) 1.54
Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat. Breast Cancer Res (2012) 1.51
Prolyl isomerase Pin1 as a molecular target for cancer diagnostics and therapeutics. Cancer Cell (2003) 1.50
Mdm2 is involved in the ubiquitination and degradation of G-protein-coupled receptor kinase 2. EMBO J (2006) 1.39
The microtubule-associated histone deacetylase 6 (HDAC6) regulates epidermal growth factor receptor (EGFR) endocytic trafficking and degradation. J Biol Chem (2010) 1.36
Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer. J Cell Sci (2003) 1.34
Histone deacetylase 6 plays a role as a distinct regulator of diverse cellular processes. FEBS J (2012) 1.31
The complex G protein-coupled receptor kinase 2 (GRK2) interactome unveils new physiopathological targets. Br J Pharmacol (2010) 1.30
Protein acetylation and histone deacetylase expression associated with malignant breast cancer progression. Clin Cancer Res (2009) 1.23
Estrogen receptor signaling as a target for novel breast cancer therapeutics. Biochem Pharmacol (2012) 1.18
GRK2: multiple roles beyond G protein-coupled receptor desensitization. Trends Pharmacol Sci (2012) 1.15
G protein-coupled receptor kinase 2 positively regulates epithelial cell migration. EMBO J (2008) 1.14
Gene expression meta-analysis identifies metastatic pathways and transcription factors in breast cancer. BMC Cancer (2008) 1.09
A novel GRK2/HDAC6 interaction modulates cell spreading and motility. EMBO J (2011) 1.08
Smoothened signaling in vertebrates is facilitated by a G protein-coupled receptor kinase. Mol Biol Cell (2008) 1.05
Mice expressing myrAKT1 in the mammary gland develop carcinogen-induced ER-positive mammary tumors that mimic human breast cancer. Carcinogenesis (2006) 1.03
How phosphorylation controls p53. Cell Cycle (2011) 0.99
G protein-coupled receptor kinase 2 (GRK2) modulation and cell cycle progression. Proc Natl Acad Sci U S A (2009) 0.99
Association of estrogen receptor alpha and histone deacetylase 6 causes rapid deacetylation of tubulin in breast cancer cells. Cancer Res (2009) 0.98
17beta-estradiol-mediated neuroprotection and ERK activation require a pertussis toxin-sensitive mechanism involving GRK2 and beta-arrestin-1. J Neurosci (2009) 0.96
The prolyl isomerase Pin1 enhances HER-2 expression and cellular transformation via its interaction with mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1. Mol Cancer Ther (2010) 0.88
Developmental and tumoral vascularization is regulated by G protein-coupled receptor kinase 2. J Clin Invest (2013) 0.87
Interdomain interactions support interdomain communication in human Pin1. Biochemistry (2013) 0.85
Raf kinase inhibitor protein (RKIP) dimer formation controls its target switch from Raf1 to G protein-coupled receptor kinase (GRK) 2. J Biol Chem (2012) 0.85
G protein-coupled receptor kinase 2 (GRK2) is a Rho-activated scaffold protein for the ERK MAP kinase cascade. Cell Signal (2013) 0.83
The prolyl isomerase Pin1 acts synergistically with CDK2 to regulate the basal activity of estrogen receptor α in breast cancer. PLoS One (2013) 0.82
The interplay between G protein-coupled receptor kinase 2 (GRK2) and histone deacetylase 6 (HDAC6) at the crossroads of epithelial cell motility. Cell Adh Migr (2012) 0.82
Grk2 is an essential regulator of CXCR7 signalling in astrocytes. Cell Mol Neurobiol (2012) 0.81
Non-catalytic participation of the Pin1 peptidyl-prolyl isomerase domain in target binding. Front Physiol (2013) 0.81